Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2012 Jan 28;287(12):8830–8838. doi: 10.1074/jbc.M111.333542

Oxoferryl-Porphyrin Radical Catalytic Intermediate in Cytochrome bd Oxidases Protects Cells from Formation of Reactive Oxygen Species*

Angela Paulus 1, Sebastiaan Gijsbertus Hendrik Rossius 1, Madelon Dijk 1, Simon de Vries 1,1
PMCID: PMC3308821  PMID: 22287551

Background: Cytochrome bd oxidases are proposed to reduce O2 to H2O via a peroxide intermediate.

Results: Kinetic studies detected, however, an oxoferryl-porphyrin radical intermediate and established insignificant production of reactive oxygen species.

Conclusion: Cytochrome bd oxidases, like heme-copper oxidases, reduce O2 in a single four-electron transfer reaction.

Significance: Both classes of terminal oxidases converged independently to minimize the production of reactive oxygen species.

Keywords: Cytochrome Oxidase, Electron Paramagnetic Resonance (EPR), Enzyme Mechanisms, Pre-steady-state Kinetics, Reactive Oxygen Species (ROS), Compound I, Cytochrome bd Oxidase, Oxoferryl Porphyrin, Cation Radical

Abstract

The quinol-linked cytochrome bd oxidases are terminal oxidases in respiration. These oxidases harbor a low spin heme b558 that donates electrons to a binuclear heme b595/heme d center. The reaction with O2 and subsequent catalytic steps of the Escherichia coli cytochrome bd-I oxidase were investigated by means of ultra-fast freeze-quench trapping followed by EPR and UV-visible spectroscopy. After the initial binding of O2, the O–O bond is heterolytically cleaved to yield a kinetically competent heme d oxoferryl porphyrin π-cation radical intermediate (compound I) magnetically interacting with heme b595. Compound I accumulates to 0.75–0.85 per enzyme in agreement with its much higher rate of formation (∼20,000 s−1) compared with its rate of decay (∼1,900 s−1). Compound I is next converted to a short lived heme d oxoferryl intermediate (compound II) in a phase kinetically matched to the oxidation of heme b558 before completion of the reaction. The results indicate that cytochrome bd oxidases like the heme-copper oxidases break the O–O bond in a single four-electron transfer without a peroxide intermediate. However, in cytochrome bd oxidases, the fourth electron is donated by the porphyrin moiety rather than by a nearby amino acid. The production of reactive oxygen species by the cytochrome bd oxidase was below the detection level of 1 per 1000 turnovers. We propose that the two classes of terminal oxidases have mechanistically converged to enzymes in which the O–O bond is broken in a single four-electron transfer reaction to safeguard the cell from the formation of reactive oxygen species.

Introduction

Cytochrome bd oxidases are membrane-bound heterodimeric terminal oxidases consisting of CydA (57 kDa) and CydB (43 kDa) (1). These oxidases occur in bacteria and archaea and catalyze the oxidation of ubiquinol or menaquinol (2). This reaction is coupled to the generation of a protonmotive force because the four chemical protons consumed per O2 are taken from the cytoplasmic side of the membrane, whereas the QH22-substrate protons are ejected into the periplasm (3, 4). Cytochrome bd oxidases bear no sequence homology to heme-copper oxidases (1) and, because they do not pump protons, have a lower bioenergetic efficiency than heme-copper oxidases (3, 4). Cytochrome bd oxidases generally have a high affinity for oxygen and are suggested to act further as oxygen scavengers and as a protection against H2O2 and NO stress (57).

Although three-dimensional structures are lacking for cytochrome bd oxidases, studies suggest that its three heme groups are all located in CydA. The low spin heme b558 is coordinated by His186–Met393, the high spin heme b595 by His19, and the chlorin heme d to Glu99 depending on the redox state (1, 815). The heme normals of b558 and b595 are parallel to the plane of the membrane (16), whereas the heme normal of heme d makes an angle of ∼55° with those of the two other hemes (16, 17). A quinone-binding domain has also been identified (1, 18, 19) that stabilizes a semiquinone (20). Spectroscopic studies suggest that hemes d and b595 are within 10 Å (21) and form a functional binuclear active site that receives electrons from heme b558, proposed as the direct electron acceptor of QH2 (13, 17, 2225). Raman spectroscopy has identified heme d2+-O2 (Oxy1)3 and heme d4+ = O (F, oxoferryl or compound II) intermediates indicating that heme d is the site for binding and conversion of O2 (2628).

The current catalytic mechanism, which has been proposed on the basis of flow-flash and stopped-flow kinetic experiments of the reaction between fully reduced enzyme and oxygen, suggests an initial binding of O2 to heme d to form the Oxy3 or A state (2931). Oxy3 is subsequently converted to a peroxy intermediate, P, with heme b595 and heme d oxidized to their ferric states, while heme b558 remains reduced. In the next step (PF) electron transfer from heme b558 and heme d leads to scission of the O–O bond followed by H2O release (29, 30). The further donation of one electron and a proton to the active site would restore the enzyme to its fully oxidized form O0, with a hydroxo-bound heme d iron. However, this form of the enzyme is probably not part of the normal catalytic cycle (31). Instead, and under physiological conditions, it is more likely that the two-electron donor QH2 reduces F to Oxy1 (heme d2+-O2) followed by reduction by a second QH2 (yielding Oxy3) to provide the necessary electrons to enter the next catalytic cycle. The as isolated or resting enzyme is usually a mixture of F and heme d2+-O2 (2628).

According to the mechanism described above, the O–O bond is broken in two sequential two-electron transfer steps via a peroxy intermediate. This mechanism differs fundamentally from that of the functionally equivalent heme-copper oxidases, which catalyze a single four-electron O–O bond splitting without a peroxy intermediate (32). The physiological advantage of the latter mechanism is the possible prevention of ROS. Indeed the production of ROS by the heme-copper oxidases has been found to be undetectably low (33, 34); in fact (all mitochondrial) ROS production is due to side reactions with O2 of other respiratory enzymes in their reduced state, notably complex I and complex III (3337). Whether cytochrome bd oxidases produce ROS is not known. If they do so, how much ROS is produced and would this be due in consequence to the formation of a peroxy intermediate?

The assignment of a catalytic peroxy intermediate was based solely on the UV-visible spectrum (29) and lacks a solid biophysical underpinning further preventing conclusions about its possible structure as a side-on, end-on, or heme-bridged peroxy species. To characterize the structure of P, the catalytic mechanism of the cytochrome bd-I oxidase from Escherichia coli was investigated using an ultrafast mixing and freeze-quenching technique (MHQ) that in addition to UV-visible enables EPR spectroscopic analyses (38, 39).

Our results indicate that cytochrome bd oxidases split the O–O bond like the heme-copper oxidases in a single four-electron transfer reaction. However, in cytochrome bd oxidases a compound I intermediate is formed, unlike the heme-copper oxidases. The amount of ROS produced by cytochrome bd oxidase was below the detection level of 1 per 1000 turnovers. We propose that both classes of terminal oxidases have convergently evolved to enzymes in which the O–O bond is broken in a single four-electron transfer reaction to minimize the cellular production of ROS.

EXPERIMENTAL PROCEDURES

Overexpression of Cytochrome bd-I Oxidase from E. coli

The cytochrome bo and bd-II knock-out strain MB30 was a donation by M. Bekker (40). MB30 was transformed with plasmid pACYC177 containing the E. coli CydAB operon overproducing cytochrome bd-I. Precultures were grown aerobically in LB medium with ampicillin (50 μg/ml) in a shaking incubator at 37 °C (∼175 rpm). Liter flasks of basal glycerol/fumarate minimal medium (41) containing ampicillin (50 μg/ml) were inoculated with 5% of the LB culture, filled to the rim, and closed, creating semi-anaerobic conditions. Cells were allowed to grow at 37 °C in a shaking incubator for ∼20 h. These starter cultures were used to inoculate (4%) four 25-liter glass vessels with basal glycerol/fumarate medium and ampicillin (5 μg/ml). Cells were grown under hypo-aerobic conditions after nitrogen flushing, while stirring at 30 °C for ∼65 h.

Purification of Cytochrome bd-I Oxidase

After a 25-fold concentration of the cell cultures in a cross-flow filtration system, the cells were harvested by centrifugation (4 °C, 10 min, 9000 × g) and washed once with 50 mm Tris-HCl buffer, pH 8. The washed cell pellets were resuspended in the same buffer prior to cell disruption at 1.8 kbar. The resulting suspension was centrifuged (4 °C, 10 min, 3000 × g) to remove cell debris. The supernatant was then centrifuged in a Beckman ultracentrifuge (4 °C, 1 h, 100,000 × g) to spin down the cell membranes containing the bd-I oxidase. Membranes were resuspended in 25 mm MOPS, pH 6.8, 1 mm EDTA and washed once or twice. The enzyme was extracted from the E. coli membranes by addition of 1% lauryl maltoside to the solution and incubating while stirring on ice for 15 min. Purification of the membrane-extracted enzyme consisted of a single column chromatography step (Q-Sepharose FastFlow) with 25 mm MOPS buffer, pH 6.8, as the running buffer. Diluted fractions were pooled by activity, concentrated, and stored at −80 °C.

Freeze-quench Experiments

MHQ, EPR, UV-visible experiments, and kinetic simulations were performed as described previously (38, 39) using the IGOR Pro software from Wavemetrics, Inc. The MHQ setup was modified just before the mixer entry with a stainless steel tubing extension immersed in ethylene glycol at −5 °C to bring the reaction temperature to 1 ± 1 °C. For kinetic experiments, purified enzyme (150 or 300 μm) in 50 mm sodium phosphate buffer, pH 7.8, 5 mm EDTA, 0.05% lauryl maltoside was made anaerobic, reduced with 2 mm sodium dithionite, and subsequently mixed with the same buffer saturated with O2. EPR spectra were normalized at the intensity of heme b595 and in separate experiments using an internal CuClO4 (0.1 mm) standard in the oxygenated buffer before mixing. Data in Fig. 5 represent the average of four independent experiments. UV-visible averaged spectra were corrected for scatter and base line as described previously (38, 39) and normalized as follows. Normalization is necessary because for the UV-visible experiments, the amounts of cold freeze-quenched powder in the low temperature cuvette is variable. Low temperature reference spectra (not prepared by MHQ) of fully reduced and “as isolated” enzyme (10 μm) were recorded in buffer, and the Soret band maxima relative to 490 nm were determined (1.0 and 0.46, respectively). The major difference in the measured maximal amplitude of the Soret band absorbance is due to the relatively sharp peak of reduced heme b558, in particular for samples after 100 μs. The relatively broad Soret peaks of the oxidized hemes contribute mainly to the difference 450–490 nm, in particular for samples after 100 μs. With these two parameters, the relative intensities of the spectra shown in Fig. 4 were calculated. From these, the fractional amount of reduced heme b558 was calculated from the spectra in the α-band region. The error in this calculation amounts to ∼0.1 heme b558 per enzyme. For the absorbance at 680 nm, the error was 0.35 per enzyme. The maximal absorbance at 680 nm was taken the same as that of oxidized heme d (cf. Ref. 29).

FIGURE 5.

FIGURE 5.

Kinetic traces of the various reaction intermediates determined from the EPR and UV-visible measurements and simulations (Red3 → CpdI → CpdII → Oxy1 kinetic sequence, see Fig. 6) using the parameters listed in Table 2. Because the system evolves to a quasi-steady state (see text), the traces of b5582+ and d3+ (Oxy1) are calculated for a total change of 0.9 and 0.8 per enzyme, respectively. For the same reason the kinetics of CpdII were calculated by the “approach to steady-state method” employing the relevant equations in Ref. 39 using the rate constants in Table 2. Data for heme b595, heme d, and CpdI are from EPR (e.g. supplemental Fig. S2) and those for CpdII and heme b558 from the UV-visible spectra in e.g. Fig. 4.

FIGURE 4.

FIGURE 4.

Low temperature of absolute UV-visible spectra of reduced cytochrome bd oxidase reacted with O2 for different times. The upper trace is the “time 0” (reduced enzyme) minus 100-μs difference spectrum, and the lower trace is the spectrum of the as-isolated enzyme. Spectra were normalized in respect to each other as described under “Experimental Procedures.” Arrows indicate the absorbance of compound I.

Determination of ROS

Spin trapping assays were performed with 25 mm DEPMPO (42) in the same buffer as above. The reaction was started by addition of 0.1 μm bd-I oxidase or 200 μm dQH2, both, or both in the presence of either catalase (1 unit) or superoxide dismutase (1 unit). The 200 μm dQH2 is fully oxidized in 20 s. Superoxide was prepared from solid KO2 in 1 m NaOH. The DEPMPO superoxide adduct has a half-life time of 17 min (42). Room temperature EPR spectra were recorded in a 100-μl aqueous sample cell 120 s after addition of the reagents and subsequently after 240 and 360 s. The spectra in Fig. 7 are the average of these three spectra. At longer reaction times, a background DEPMPO radical developed in the presence of dQH2. Similar experiments with 400 μm ferrous cytochrome c + 0.1 μm Paracoccus denitrificans cytochrome aa3 oxidase produced a background signal after ∼200 s, limiting the detection level of the assay with cytochrome aa3 oxidase to one ROS per 250 turnovers.

FIGURE 7.

FIGURE 7.

Room temperature EPR spectra of DEPMPO-O2 adduct (upper three spectra) and of cytochrome bd oxidase reacted in various ways to detect possible formation of the DEPMPO-O2 or other (e.g. OOH) adducts during the reaction. None are seen in the complete reaction (bd/dQH2), or in the controls with superoxide dismutase (bd/dQH2/SOD), or catalase (bd/dQH2/Cat), or in the presence of only enzyme (bd) or substrate (dQH2). The DEPMPO- O2 adduct at 1.5 μm was prepared as described under “Experimental Procedures.” The traces of 0.4 and 0.1 μm were calculated from the 1.5 μm spectrum by multiplication of 0.27 and 0.067, respectively, and then adding a random noise function with the same noise as the experimental spectrum. The detection DEPMPO-O2 limit is below ∼0.1 μm, because in this (calculated) spectrum the S/N ratio is ∼<1. Microwave frequency, 9.79 GHz, modulation amplitude, 0.1 millitesla, microwave power, 20 milliwatt.

The Amplex Red hydrogen peroxide/peroxidase assay was performed according to the manufacturer's protocol (Invitrogen). The final assay volume of 80 μl each consisted of 50 μl of the Amplex Red reagent/HRP working solution; to this 30 μl of buffer was added yielding the same final enzyme and reagent concentrations as used for EPR. The formation of resorufin was monitored at 550 nm in an HP Agilent 8453 diode array spectrophotometer in 1-min intervals after manual mixing of the enzymatic solution with the reagent working solution. All assays were performed at room temperature, and a background trace was recorded for each assay. The background reaction with dQH2 limits the sensitivity of the assay to ∼1 H2O2 per 1000 turnovers of the cytochrome bd oxidase. The assay could not be performed successfully with cytochrome aa3 oxidase because of spectral overlap of resorufin and ferrous cytochrome c.

RESULTS

Heme d Oxoferryl Porphyrin π-Cation Radical Intermediate (Compound I) Detected by EPR Spectroscopy

To study the mechanism of O–O bond splitting by the cytochrome bd oxidase, single turnover experiments were performed at 1 °C to slow down the reaction. After the reaction between reduced enzyme and O2, intermediates were trapped by means of freeze-quenching at times ≥100 μs and analyzed by EPR and low temperature UV-visible spectroscopy.

The EPR spectrum of as-isolated cytochrome bd oxidase displays resonances from two high spin heme species, the axial heme d (g ∼6) and the rhombic heme b595 (gx ∼6.2 and gy ∼5.7) and a third signal from the low spin heme b558 (gz = 3.58) (cf. Fig. 1) (24, 43). The reduced enzyme is EPR-silent. After reacting for 100 μs, heme b595 became fully oxidized (Fig. 1, middle trace), whereas only ∼0.1–0.2 heme d had converted to the ferric state. The middle trace in Fig. 1 further shows a previously undetected intermediate at 3100–3500 G, which is argued below to be a compound I derivative of heme d. The new EPR signal (Fig. 2 and supplemental Fig. S1) consists of three overlapping signals arising from three rhombic S = ½ spin systems when recorded at 4.2 K. At higher temperatures the line shapes of the three EPR signals change and coalesce at 77 K into a single rhombic signal with g values that are the average of the individual signals (Table 1 and supplemental Fig. S1). At 4.2 K the integrated intensity of the three signals together accounts for 0.75–0.85 spins per enzyme. The unusual temperature dependence of the EPR signals is due to a magnetic dipolar interaction between oxidized heme b595 and the compound I, a conclusion that will be explained below.

FIGURE 1.

FIGURE 1.

EPR spectra of freeze-quenched samples of cytochrome bd oxidase. Top, as isolated enzyme (“infinite time”); middle, after reaction for 100 μs with O2; bottom, fully reduced enzyme (“zero time”). The (partial) upper spectrum shows the gz resonance of the low spin heme b558 at g = 3.58 from a 25-fold concentrated as isolated enzyme solution; the peak at g = 3.58 is too weak to be detected in freeze-quenched samples. The peak at g = 4.3 is from adventitious iron, the broad peak around 3200 G from adventitious Cu2+ in the cavity, and the sharp signal at ∼3380 G is due to the freeze-quench procedure. EPR conditions are as follows: Microwave frequency, 9.45 GHz; modulation amplitude, 0.5 millitesla; microwave power, 20 microwatts; temperature, 4.2 K. Full traces are displayed at the same gain.

FIGURE 2.

FIGURE 2.

EPR spectra of compound I (after 100 μs) at different temperatures between 4.2 and 77 K and simulations. The EPR spectrum recorded at 4.2 K is simulated as a sum of three signals in a ratio of 0.4:0.3:0.3 for signal 1, signal 2, and signal 3, respectively. The intensities of the spectra are corrected for differences in temperature, microwave power (20 microwatt to 5 milliwatts), and gain. The dots indicate the artificial signals due to the freeze-quench procedure.

TABLE 1.

Compound I EPR parameters

Compound I type gx gy gz
Signal at 77 K 2.157 2.112 1.973
Signal 1 at 4.2 K 2.173 2.092 1.973
Signal 2 at 4.2 K 2.158 2.128 1.973
Signal 3 at 4.2 K 2.146 2.131 1.973

The magnetic properties of compound I are well understood (supplemental material) (44, 45). Briefly, compound I comprises an S = 1 heme oxoferryl center (Fe4+=O) that is magnetically coupled to a S = ½ porphyrin π-cation radical. The coupling of the two spins yields three Kramer's doublets (cf. Fig. 3B) yielding either an S = ½ or S = 3/2 ground state, which depends on the relative magnitudes and signs of the Heisenberg exchange interaction (J) between the Fe4+=O and the porphyrin radical and further on the zero-field splitting (D) of the S = 1 species. The finding here that the three g values are close to g = 2 indicates a total spin of S = ½ for the ground state of the compound I. The Kramer doublets are separated in energy by an amount Δ (∼D) and J. Because Δ is usually quite small, 20–40 cm−1, compound I species follow a two-phonon Orbach relaxation mechanism. The presence of a low-lying first excited state will also result in significant loss of spin intensity at temperatures greater than Δ (i.e. above ∼30 K). Hence, to validate the assignment as compound I, both the relaxation behavior and the ground state population were determined (Fig. 3). Both these experiments should yield a similar value for Δ (46).

FIGURE 3.

FIGURE 3.

Saturation behavior (A) and ground state population (B) of compound I as a function of temperature. Data in A were fitted to ln(P½) = ln(A·T + B·(eΔ/T − 1)−1), where A·T represents the direct process (A = 22 microwatts/K) and the second term the Orbach relaxation (B = 4.2 megawatts). Ground state population in B was calculated with the equation: (1 + e−Δ/T + e−(Δ+J)/T)−1. Values of Δ and (Δ + J) are given in the text. The three Kramer's doublets and their energy separations are shown in the lower inset in B.

The increase of the relaxation rate upon increasing the temperature follows an Orbach relaxation mechanism at T >4.2 K (Fig. 3A) for a first excited state at Δ = 36.8 ± 4.8 cm−1. The decrease of spin intensity corresponds to the presence of excited states that are 32.2 ± 10.4 cm−1 (Δ) and 33.9 ± 11.7 cm−1 (Δ + J), respectively, above the ground state (Fig. 3B). The latter two values indicate a small value for J of ∼2 cm−1 or Δ <0.1 J. Such a small value for J (either negative or positive) relative to Δ (or D) is consistent with g values close to g = 2 (Table 1), and in fact is quite similar to those calculated for the isolated S = 1 Fe(IV) system for which J = 0 (47). The value gz = 1.973 determined here is consistent with a calculated value for D (or Δ) of ∼30 cm−1 (47) and close to that determined here. The decrease of the ground state spin population rules out that the EPR signal is derived from a ferric heme peroxy center for which the first excited state lies at >700 cm−1, determined by the strength of the crystal field (supplemental material) (48). In addition, the g values would be very unusual for low spin heme centers.

The observation that the compound I EPR signal is split into three signals (Figs. 1 and 2 and supplemental Fig. S1) with similar intensities suggests that compound I is coupled to a nearby anisotropic magnet for which at 4.2 K the relaxation is much slower than that of compound I, whereas at higher temperatures the reverse holds. At T > 60 K, the relaxation of this magnet is so fast that the splitting averages out resulting at 77 K in a compound I signal with g values that are the average of those at 4.2 K (Table 1). Previous studies have provided evidence for magnetic interactions between ferric heme d and heme b595 (9, 24, 43). We therefore propose an anisotropic magnetic dipolar interaction between the heme d-derived compound I and heme b595. At high temperatures, the relaxation of the ferric heme b595 is much faster than that of compound I, consistent with the detection of an EPR signal of the latter at 77 K but not of heme b595 (see supplemental material). Interestingly, the splitting is much more pronounced in the gx,y resonances than in the gz peak. The gz is directed along the Fe4+=O bond, perpendicular to the plane of heme d. Because the angle between the heme d and heme b595 normals is ∼55° (16, 17), which is close to the magic angle of 54.7° at which the magnetic dipolar coupling is zero, the small splitting in the gz resonance is consistent with this angle determined by other methods. We conclude that the new EPR signal is from a heme d oxoferryl porphyrin π-cation radical in dipolar magnetic interaction with heme b5953+.

Compound I Species Detected by UV-visible Spectroscopy

Fig. 4 shows low temperature UV-visible spectra of the reaction between cytochrome bd-I oxidase and O2. After 100 μs, the peak of heme d at 624 nm has shifted to 641 nm and broadened considerably, whereas heme b558 has remained largely reduced (75–85%). In agreement with the EPR spectra (Fig. 1), heme b595 is completely oxidized after 100 μs indicated by the disappearance of the broad absorbance around 595 nm and the appearance of a negative peak in the Soret region (439 nm) in the “0–100-μs” difference spectrum (49). This difference spectrum further indicates the appearance of a broad absorbance at 404 nm. The peak at 404 nm (and that at 641 nm) is ascribed to that of the heme d compound I intermediate. In agreement with this are the blue shifts from ∼430 nm for the ferrous state to 404 nm and the low extinction, ∼25–30% of the intensity of the Soret band of heme b595, two features also observed for compound I from horseradish peroxidase (50). The compound I absorbance is also directly visible in the absolute spectra of Fig. 4 as a shoulder at 404 nm on the Soret peaks of hemes b595 and b558. This shoulder disappears as the reaction proceeds. Difference spectra calculated for times >100 μs did not resolve the 404-nm band as well as after 100 μs because of spectral interference from hemes b558 and d, the latter changing to the ferric state at longer reaction times. In contrast, the intermediate state obtained after 100 μs is quite pure, i.e. full oxidation of heme b595, >75% change of heme d2+ to heme d4+=O, <25% heme d3+, and <25% change of heme b2+558 to b3+558.

Kinetic Analysis

The time-dependent redox changes calculated from UV-visible and EPR spectra are shown in Figs. 4 and 5 and supplemental Fig. S2. The formation of compound I within 100 μs is followed by the slower oxidation of heme b558 (Fig. 4) and by optical changes in the Soret region and around 640 nm because of formation of heme d3+, also observed by an increase of the signal at g ∼ 6 (supplemental Fig. S2). In the same time window, the EPR signal of compound I disappears (supplemental Fig. S2). The absorbance changes at 680 nm (F) are small and difficult to analyze due to sloping base lines. F is estimated to accumulate to ∼0.1 per enzyme and did not show the transient behavior expected for a true intermediate. The lack of this transient and the remaining 15–20% reduction of heme b558 after 2 ms are explained by the slight excess of reductant present (sodium dithionite), which renders the oxidation kinetics not pure single turnover; instead, the enzyme reaches a quasi steady state. Here, heme d is ∼80% oxidized with the remainder present as F and a small amount of heme d2+-O2 represented by the absorbance at 646 nm (cf. 2628). This electronic distribution is in agreement with experiments that show that F and Oxy1 are dominant steady-state species (51). Note that the 680 nm band is also present in the enzyme as isolated (Fig. 4) (2628) but that heme d2+-O2 is absent in our preparation.

EPR spectroscopy (supplemental Fig. S2) shows that as compound I disappeared and heme d3+ is formed, the line shape of heme b595, in particular the g ∼ 5.7 derivative-like resonance, shifts by ∼ 10 G. The small shift is interpreted as a change in magnetic interaction between heme b595 and heme d, as the latter changes from the compound I state to the ferric state. After 2 ms, the EPR spectrum of the high spin heme centers is similar to that of the “as-isolated enzyme.”

The kinetic profiles of the various intermediates determined from the UV-visible and EPR spectra are shown in Fig. 5, and the calculated rate constants are listed in Table 2. The rates of oxygen binding, heme b595 oxidation, and compound I formation were too fast to be determined directly in this study, even at the reaction temperature of 1 °C, where these reactions appear completed within 100 μs. Flow-flash experiments (29) indicate a 10-fold lower rate of oxidation of heme b558 than the preceding reactions suggesting a (combined) rate of ∼20,000 s−1 for oxygen binding, oxidation of heme b595, and compound I formation (cf. Table 2). The accumulation of compound I to 0.75–0.85 per enzyme is consistent with the ∼10-fold higher rate of its formation than its rate of decay (Table 2).

TABLE 2.

Rate constants at 1 °C for various intermediate steps of the cytochrome bd oxidase catalytic cycle

Species k
s1
b5952+ oxidationa 20,000 ± 2000
Compound I decay 1950 ± 200
b5582+ oxidation 1850 ± 400
Compound II decay 7300 ± 2500
d3+ formation 1250 ± 100

a Data include the rate of O2 binding. Estimated from Ref. 29 and this work.

Significantly, the rates of compound I decay and oxidation of heme b558 are the same, but the formation of heme d3+ is slower (Table 2). The similar rates of compound I decay and heme b558 oxidation are consistent with the view that electron transfer from heme b558 leads to direct reduction of the porphyrin π-cation radical, thus producing the ferryl form of heme d or F. In the subsequent reaction F, which barely accumulates, is rapidly reduced further, by excess reductant, yielding heme d3+. The rate of compound II reduction is calculated at ∼7300 s−1 based on the experimental time delay between compound I decay and heme d3+ formation and the accumulation to 0.1 per enzyme estimated from the 680 nm absorbance.

DISCUSSION

Catalytic Mechanism

The reduction of O2 by reduced cytochrome bd oxidase will in general not yield clean (pseudo-) first-order traces because the complete reaction needs four electrons, and the enzyme can store only three. In our experiments, the small excess reductant leads to rapid net 4–5 electron transfer leaving some reduced enzyme after 2 ms that is slowly oxidized in a quasi-steady state in which excess reductant and remaining oxygen are exhausted. In the flow-flash experiments, F was formed almost stoichiometrically in 47 μs, apparently corresponding to a net three-electron reaction (29). In the next step (∼1.1 ms), F was converted to a mixture of oxidized and oxygenated enzyme as observed here. The transient kinetics of F in the flow-flash experiments show that it is a true intermediate. The nontransient kinetics of F in our experiments might suggest that it is not part of the main catalytic pathway but, for example, in rapid equilibrium with another/unknown intermediate. However, because the reaction proceeds to a quasi-steady state, also a true intermediate may show nontransient kinetics.

The optical and kinetic properties of the intermediate formed after 100 μs with peaks at 404 and 641 nm are the same as those observed for the peroxy intermediate P formed after 4.5 μs (peak at 635 nm at 20 °C (29)). The assignment as a peroxy intermediate by the authors was based solely on UV-visible spectroscopy and on the notion that formation of compound I “is not very likely, because it would require oxidation of a nearby amino acid residue or the porphyrin ring that is energetically unfavorable in the presence of the reduced heme b558 in the proximity of the catalytic center” (29). Here, we provide both EPR and UV-visible spectroscopic evidence that the intermediate labeled P in Ref. 29 is in fact compound I. We therefore propose a new reaction mechanism for the cytochrome bd oxidase (Fig. 6). Accordingly, after binding of O2 to the fully reduced enzyme (Red3) in which Oxy3 is formed, the O–O bond is split in a single four-electron reaction producing within 100 μs the compound I intermediate (CpdI or F+*) without formation of a peroxy state. Oxygen bond breaking is accomplished in an apparently concerted electron transfer reaction from heme b595, heme d (two electrons), and the heme d porphyrin moiety. The obligatory proton donor needed for O–O bond splitting remains unknown. The subsequent internal electron transfer from heme b558 (525 μs) converts CpdI into CpdII (or F). Rapid electron transfer from dithionite or from endogenous QH2 (1–2 electrons per enzyme) produces a largely oxidized enzyme after 2 ms and a mixture of some heme b5582+, Oxy1, and CpdII. The formation of kinetically competent compound I and II intermediates by the cytochrome bd oxidases resembles the mechanism of plant peroxidases and eukaryotic catalases. The catalytic mechanism of cytochrome bd oxidases is similar to that of heme-copper oxidases, which also break the O–O bond in a single four-electron transfer. However, in the heme-copper oxidases, PM rather than Cpd1 is formed initially, i.e. a heme a3 oxoferryl intermediate plus an amino acid radical, most likely a tyrosine radical (52).

FIGURE 6.

FIGURE 6.

Proposal for the catalytic cycle of cytochrome bd oxidase. Half-lives (in microseconds) of the various steps are indicated. Protons needed in some of the reactions are omitted from the figure. The heme normals of heme d and heme b595 make an angle of ∼55°, suggested here by the nonparallel porphyrin plane of heme d, although not drawn at 55°. See text for further explanation of the catalytic mechanism. The superscripts in O1, Oxy1, Oxy3, and Red3 refer to the total number of electrons in the heme centers of the enzyme.

ROS Production

Breaking the O–O bond in a single four-electron transfer represents a mechanism to protect the cell from ROS production during aerobic growth. Possible production of ROS was determined by the EPR spin trapping assay with DEPMPO (42) and the UV-visible based Amplex Red reagent assay. The sensitivity of the Amplex Red assay is limited by a slow background reaction and the spin trapping method by the DEPMPO-derivative stability, its EPR detection limit, and the dQH2 solubility of 200 μm limiting the number of turnovers. Both methods indicated that the production of ROS by cytochrome bd oxidase was below the detection limit of <1 per 1000 turnovers, i.e. less than 0.1 μm O2 or H2O2 produced per 100 μm O2 consumed (cf. Fig. 7). The production of ROS by purified P. denitrificans cytochrome aa3 oxidase was determined at <1 per 250 turnovers, a relatively high value because of the presence of a background signal. However, the production of ROS by the similar mitochondrial cytochrome aa3 oxidase has previously been estimated to be much lower than 1/250 turnovers (3335, 53). In fact ROS production is too low to detect mainly due to the contribution by other respiratory enzymes. In vivo ROS production by mitochondria is estimated at ∼1 per 1000 turnovers of the respiratory chain (53) and possibly similar in bacteria (54). If terminal oxidases indeed produce negligible amounts of ROS, as is generally believed, their contribution should be below ∼1 per 10,000 turnovers, a value too low to measure directly with current techniques. Because both classes of terminal oxidases break the O–O bond in a single four-electron transfer, significant production of H2O2 and OH is considered unlikely, but production of O2 cannot be completely prevented because of the Fe2+-O2 ↔ Fe3+-O2˙̄ equilibrium in the initial oxy-derivative. Resonance Raman spectroscopy on the two classes of terminal oxidases and oxymyoglobin indeed shows considerable superoxide character for the oxy-complexes (27, 55, 56). The release of O2˙̄ by oxymyoglobin is, however, very slow (t½ ∼10 h (57)) among others because of its high midpoint potential (∼0.1 V) (58). In the terminal oxidases the midpoint potentials of the hemes are even higher (∼0.3 V) (43, 52), which would most likely result in even slower release of O2˙̄. In addition, the oxy-complexes of the terminal oxidases are rapidly (∼<10 μs) converted to Cpd1 or to PM yielding a calculated O2˙̄ production of <1 per 109 turnovers, far below current detection levels and far below that of other respiratory complexes.

It appears that the cytochrome bd oxidases and heme-copper oxidases have evolved independently to minimize if not prevent production of ROS by very rapidly breaking the O–O bond in an apparently concerted single four-electron transfer and protonation reaction. To do so, both classes of terminal oxidases harbor a compact bi-metallic center integrated with a nearby proton donor. This bi-metallic center contains one metal ion able to attain the Fe4+ state and an additional redox center, either the porphyrin ring itself, or a nearby amino acid as donor of the fourth electron. In the single heme-containing peroxidases, catalases, and cytochrome P450 enzymes, the same natural variation is observed that the porphyrin ring or a nearby amino acid such as Trp or Tyr donates the extra electron to cleave the peroxy O–O bond (44, 45, 5961).

Supplementary Material

Supplemental Data

Acknowledgments

We thank Prof. Dr. W. R. Hagen (Delft University of Technology) for discussions on EPR, Prof. Dr. I. Schröder (UCLA) for suggestions regarding the overexpression of the cytochrome bd oxidase, and Dr. H. R. C. Dietrich, Ing. M. J. F. Strampraad, and Ing. E. Yildirim for various contributions to this research.

*

This work was supported by ECHO Grant 700.54.003 from the Netherlands Organization for Scientific Research (to S. d. V.).

This paper is dedicated to the memories of Profs. Thomas M. Loehr and Joann Sanders-Loehr, both pioneers in the field of resonance Raman spectroscopy on metallo-enzymes, including the cytochrome bd oxidase. S. de Vries cherishes the collaborations in science and their warm friendship.

3

The superscripts in O1, Oxy1, Oxy3, and Red3 refer to the total number of electrons in the heme centers of the enzyme.

2
The abbreviations used are:
QH2
ubiquinol
ROS
reactive oxygen species
CpdI or CpdII
compound II or CpdII, oxoferryl porphyrin π-cation radical; oxoferryl
MHQ
microsecond freeze-hyperquenching
DEPMPO
(5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide)
dQH2
decylubiquinol
HRP
horse radish peroxidase.

REFERENCES

  • 1. Osborne J. P., Gennis R. B. (1999) Sequence analysis of cytochrome bd oxidase suggests a revised topology for subunit I. Biochim. Biophys. Acta 1410, 32–50 [DOI] [PubMed] [Google Scholar]
  • 2. Schröder I., de Vries S. (2008) in Archaea: New Models for Prokaryotic Biology (Blum P., ed) pp. 1–26, Caister Academic Press, Hethersett, Norwich, UK [Google Scholar]
  • 3. Puustinen A., Finel M., Haltia T., Gennis R. B., Wikström M. (1991) Properties of the two terminal oxidases of Escherichia coli. Biochemistry 30, 3936–3942 [DOI] [PubMed] [Google Scholar]
  • 4. Borisov V. B., Murali R., Verkhovskaya M. L., Bloch D. A., Han H., Gennis R. B., Verkhovsky M. I. (2011) Aerobic respiratory chain of Escherichia coli is not allowed to work in fully uncoupled mode. Proc. Natl. Acad. Sci. U.S.A. 108, 17320–17324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Baughn A. D., Malamy M. H. (2004) The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 427, 441–444 [DOI] [PubMed] [Google Scholar]
  • 6. Mason M. G., Shepherd M., Nicholls P., Dobbin P. S., Dodsworth K. S., Poole R. K., Cooper C. E. (2009) Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nat. Chem. Biol. 5, 94–96 [DOI] [PubMed] [Google Scholar]
  • 7. Borisov V. B., Forte E., Sarti P., Brunori M., Konstantinov A. A., Giuffrè A. (2006) Nitric oxide reacts with the ferryl-oxo catalytic intermediate of the CuB-lacking cytochrome bd terminal oxidase. FEBS Lett. 580, 4823–4826 [DOI] [PubMed] [Google Scholar]
  • 8. Borisov V. B., Belevich I., Bloch D. A., Mogi T., Verkhovsky M. I. (2008) Glutamate 107 in subunit I of cytochrome bd from Escherichia coli is part of a transmembrane intraprotein pathway conducting protons from the cytoplasm to the heme b595/heme d active site. Biochemistry 47, 7907–7914 [DOI] [PubMed] [Google Scholar]
  • 9. Jünemann S. (1997) Cytochrome bd terminal oxidase. Biochim. Biophys. Acta 1321, 107–127 [DOI] [PubMed] [Google Scholar]
  • 10. Kaysser T. M., Ghaim J. B., Georgiou C., Gennis R. B. (1995) Methionine 393 is an axial ligand of the heme b558 component of the cytochrome bd ubiquinol oxidase from Escherichia coli. Biochemistry 34, 13491–13501 [DOI] [PubMed] [Google Scholar]
  • 11. Mogi T. (2009) Probing the heme d-binding site in cytochrome bd quinol oxidase by site-directed mutagenesis. J. Biochem. 145, 763–770 [DOI] [PubMed] [Google Scholar]
  • 12. Mogi T., Endou S., Akimoto S., Morimoto-Tadokoro M., Miyoshi H. (2006) Glutamates 99 and 107 in transmembrane helix III of subunit I of cytochrome bd are critical for binding of the heme b595-d binuclear center and enzyme activity. Biochemistry 45, 15785–15792 [DOI] [PubMed] [Google Scholar]
  • 13. Sun J., Kahlow M. A., Kaysser T. M., Osborne J. P., Hill J. J., Rohlfs R. J., Hille R., Gennis R. B., Loehr T. M. (1996) Resonance Raman spectroscopic identification of a histidine ligand of b595 and the nature of the ligation of chlorine d in the fully reduced Escherichia coli cytochrome bd oxidase. Biochemistry 35, 2403–2412 [DOI] [PubMed] [Google Scholar]
  • 14. Tsubaki M., Uno T., Hori H., Mogi T., Nishimura Y., Anraku Y. (1993) Cytochrome d axial ligand of the bd-type terminal quinol oxidase from Escherichia coli. FEBS Lett. 335, 13–17 [DOI] [PubMed] [Google Scholar]
  • 15. Yang K., Zhang J., Vakkasoglu A. S., Hielscher R., Osborne J. P., Hemp J., Miyoshi H., Hellwig P., Gennis R. B. (2007) Glutamate 107 in subunit I of the cytochrome bd quinol oxidase from Escherichia coli is protonated and near the heme d/heme b595 binuclear center. Biochemistry 46, 3270–3278 [DOI] [PubMed] [Google Scholar]
  • 16. Ingledew W. J., Rothery R. A., Gennis R. B., Salerno J. C. (1992) The orientation of the three hemes of the “in situ” ubiquinol oxidase, cytochrome bd, of Escherichia coli. Biochem. J. 282, 255–259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Borisov V. B., Liebl U., Rappaport F., Martin J. L., Zhang J., Gennis R. B., Konstantinov A. A., Vos M. H. (2002) Interactions between heme d and heme b595 in quinol oxidase bd from Escherichia coli. A photoselection study using femtosecond spectroscopy. Biochemistry 41, 1654–1662 [DOI] [PubMed] [Google Scholar]
  • 18. Yang F. D., Yu L., Yu C. A., Lorence R. M., Gennis R. B. (1986) Use of an azido-ubiquinone derivative to identify subunit I as the ubiquinol-binding site of the cytochrome d terminal oxidase complex of Escherichia coli. J. Biol. Chem. 261, 14987–14990 [PubMed] [Google Scholar]
  • 19. Zhang J., Hellwig P., Osborne J. P., Huang H. W., Moënne-Loccoz P., Konstantinov A. A., Gennis R. B. (2001) Site-directed mutation of the highly conserved region near the Q-loop of the cytochrome bd quinol oxidase from Escherichia coli specifically perturbs heme b595. Biochemistry 40, 8548–8556 [DOI] [PubMed] [Google Scholar]
  • 20. Hastings S. F., Kaysser T. M., Jiang F., Salerno J. C., Gennis R. B., Ingledew W. J. (1998) Identification of a stable semiquinone intermediate in the purified and membrane-bound ubiquinol oxidase-cytochrome bd from Escherichia coli. Eur. J. Biochem. 255, 317–323 [DOI] [PubMed] [Google Scholar]
  • 21. Arutyunyan A. M., Borisov V. B., Novoderezhkin V. I., Ghaim J., Zhang J., Gennis R. B., Konstantinov A. A. (2008) Strong excitonic interactions in the oxygen-reducing site of bd-type oxidase. The Fe-to-Fe distance between hemes d and b595 is 10 Å. Biochemistry 47, 1752–1759 [DOI] [PubMed] [Google Scholar]
  • 22. Hata-Tanaka A., Matsuura K., Itoh S., Anraku Y. (1987) Electron flow and heme-heme interaction between cytochromes b-558, b-595, and d in a terminal oxidase of Escherichia coli. Biochim. Biophys. Acta 893, 289–295 [DOI] [PubMed] [Google Scholar]
  • 23. Hill J. J., Alben J. O., Gennis R. B. (1993) Spectroscopic evidence for a heme-heme binuclear center in the cytochrome bd ubiquinol oxidase from Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 90, 5863–5867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Jünemann S., Wrigglesworth J. M. (1995) Cytochrome bd oxidase from Azotobacter vinelandii. Purification and quantitation of ligand binding to the oxygen reduction site. J. Biol. Chem. 270, 16213–16220 [DOI] [PubMed] [Google Scholar]
  • 25. Rappaport F., Zhang J., Vos M. H., Gennis R. B., Borisov V. B. (2010) Heme-heme and heme-ligand interactions in the di-heme oxygen-reducing site of cytochrome bd from Escherichia coli revealed by nanosecond absorption spectroscopy. Biochim. Biophys. Acta 1797, 1657–1664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kahlow M. A., Zuberi T. M., Gennis R. B., Loehr T. M. (1991) Identification of a ferryl intermediate of Escherichia coli cytochrome d terminal oxidase by resonance Raman spectroscopy. Biochemistry 30, 11485–11489 [DOI] [PubMed] [Google Scholar]
  • 27. Poole R. K., Baines B. S., Hubbard J. A. M., Hughes M. N., Campbell N. J. (1982) Resonance Raman spectroscopy of an oxygenated intermediate species of cytochrome oxidase d from Escherichia coli. FEBS Lett. 150, 147–150 [Google Scholar]
  • 28. Sun J., Osborne J. P., Kahlow M. A., Kaysser T. M., Hil J. J., Gennis R. B., Loehr T. M. (1995) Resonance Raman studies of Escherichia coli cytochrome bd oxidase. Selective enhancement of the three heme chromophores of the “as-isolated” enzyme and characterization of the cyanide adduct. Biochemistry 34, 12144–12151 [DOI] [PubMed] [Google Scholar]
  • 29. Belevich I., Borisov V. B., Verkhovsky M. I. (2007) Discovery of the true peroxy intermediate in the catalytic cycle of terminal oxidases by real time measurement. J. Biol. Chem. 282, 28514–28519 [DOI] [PubMed] [Google Scholar]
  • 30. Hill B. C., Hill J. J., Gennis R. B. (1994) The room temperature reaction of carbon monoxide and oxygen with the cytochrome bd quinol oxidase from Escherichia coli. Biochemistry 33, 15110–15115 [DOI] [PubMed] [Google Scholar]
  • 31. Yang K., Borisov V. B., Konstantinov A. A., Gennis R. B. (2008) The fully oxidized form of the cytochrome bd quinol oxidase from E. coli does not participate in the catalytic cycle: direct evidence from rapid kinetics studies. FEBS Lett. 582, 3705–3709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Babcock G. T., Wikström M. (1992) Oxygen activation and the conservation of energy in cell respiration. Nature 356, 301–309 [DOI] [PubMed] [Google Scholar]
  • 33. Boveris A., Chance B. (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134, 707–716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Hinkle P. C., Butow R. A., Racker E., Chance B. (1967) Partial resolution of the enzymes catalyzing oxidative phosphorylation. XV. Reverse electron transfer in the flavin-cytochrome β region of the respiratory chain of beef heart submitochondrial particles. J. Biol. Chem. 242, 5169–5173 [PubMed] [Google Scholar]
  • 35. Cadenas E., Boveris A., Ragan C. I., Stoppani A. O. (1977) Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180, 248–257 [DOI] [PubMed] [Google Scholar]
  • 36. Dröse S., Brandt U. (2008) The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J. Biol. Chem. 283, 21649–21654 [DOI] [PubMed] [Google Scholar]
  • 37. Kussmaul L., Hirst J. (2006) The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci. U.S.A. 103, 7607–7612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Cherepanov A. V., De Vries S. (2004) Microsecond freeze-hyperquenching. Development of a new ultrafast micro-mixing and sampling technology and application to enzyme catalysis. Biochim. Biophys. Acta 1656, 1–31 [DOI] [PubMed] [Google Scholar]
  • 39. Wiertz F. G., Richter O. M., Ludwig B., de Vries S. (2007) Kinetic resolution of a tryptophan-radical intermediate in the reaction cycle of Paracoccus denitrificans cytochrome c oxidase. J. Biol. Chem. 282, 31580–31591 [DOI] [PubMed] [Google Scholar]
  • 40. Bekker M., de Vries S., Ter Beek A., Hellingwerf K. J., de Mattos M. J. (2009) Respiration of Escherichia coli can be fully uncoupled via the nonelectrogenic terminal cytochrome bd-II oxidase. J. Bacteriol. 191, 5510–5517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Spencer M. E., Guest J. R. (1974) Proteins of the inner membrane of Escherichia coli. Changes in composition associated with anaerobic growth and fumarate reductase amber mutation. J. Bacteriol. 117, 954–959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Frejaville C., Karoui H., Tuccio B., Le Moigne F., Culcasi M., Pietri S., Lauricella R., Tordo P. (1995) 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide. A new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J. Med. Chem. 38, 258–265 [DOI] [PubMed] [Google Scholar]
  • 43. Meinhardt S. W., Gennis R. B., Ohnishi T. (1989) EPR studies of the cytochrome-d complex of Escherichia coli. Biochim. Biophys. Acta 975, 175–184 [DOI] [PubMed] [Google Scholar]
  • 44. Fujii H., Yoshimura T., Kamada H. (1996) ESR studies of A(1u) and A(2u) oxoiron(IV) porphyrin π-cation radical complexes. Spin coupling between ferryl Iron and A(1u)/A(2u) orbitals. Inorg. Chem. 35, 2373–2377 [DOI] [PubMed] [Google Scholar]
  • 45. Houseman A. L., Doan P. E., Goodin D. B., Hoffman B. M. (1993) Comprehensive explanation of the anomalous EPR spectra of wild-type and mutant cytochrome c peroxidase compound ES. Biochemistry 32, 4430–4443 [DOI] [PubMed] [Google Scholar]
  • 46. Mandon D., Weiss R., Jayaraj K., Gold A., Terner J., Bill E., Trautwein A. X. (1992) Models for peroxidase compound I: generation and spectroscopic characterization of new oxoferryl porphyrin π cation radical species. Inorg. Chem. 31, 4404–4409 [Google Scholar]
  • 47. Oosterhuis W. T., Lang G. (1973) Magnetic properties of the t42g configuration in low symmetry crystal fields. J. Chem. Phys. 58, 4757–4765 [Google Scholar]
  • 48. Zoppellaro G., Bren K. L., Ensign A. A., Harbitz E., Kaur R., Hersleth H. P., Ryde U., Hederstedt L., Andersson K. K. (2009) Review. Studies of ferric heme proteins with highly anisotropic/highly axial low spin (S = 1/2) electron paramagnetic resonance signals with bis-histidine and histidine-methionine axial iron coordination. Biopolymers 91, 1064–1082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Vos M. H., Borisov V. B., Liebl U., Martin J. L., Konstantinov A. A. (2000) Femtosecond resolution of ligand-heme interactions in the high affinity quinol oxidase bd. A di-heme active site? Proc. Natl. Acad. Sci. U.S.A. 97, 1554–1559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Hewson W. D., Hager L. P. (1979) Oxidation of horseradish peroxidase compound II to compound I. J. Biol. Chem. 254, 3182–3186 [PubMed] [Google Scholar]
  • 51. Borisov V. B., Forte E., Sarti P., Giuffrè A. (2011) Catalytic intermediates of cytochrome bd terminal oxidase at steady state. Ferryl and oxy-ferrous species dominate. Biochim. Biophys. Acta 1807, 503–509 [DOI] [PubMed] [Google Scholar]
  • 52. Kaila V. R., Verkhovsky M. I., Wikström M. (2010) Proton-coupled electron transfer in cytochrome oxidase. Chem. Rev. 110, 7062–7081 [DOI] [PubMed] [Google Scholar]
  • 53. Murphy M. P. (2009) How mitochondria produce reactive oxygen species. Biochem. J. 417, 1–13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Korshunov S., Imlay J. A. (2006) Detection and quantification of superoxide formed within the periplasm of Escherichia coli. J. Bacteriol. 188, 6326–6334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Han S. W., Ching Y. C., Rousseau D. L. (1990) Primary intermediate in the reaction of oxygen with fully reduced cytochrome c oxidase. Proc. Natl. Acad. Sci. U.S.A. 87, 2491–2495 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Tsubaki M., Yu N. T. (1981) Resonance Raman investigation of dioxygen bonding in oxycobalt myoglobin and oxycobalt hemoglobin. Structural implication of splittings of the bound O–O stretching vibration. Proc. Natl. Acad. Sci. U.S.A. 78, 3581–3585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Goto T., Shikama K. (1974) Autoxidation of native oxymyoglobin from bovine heart muscle. Arch. Biochem. Biophys. 163, 476–481 [DOI] [PubMed] [Google Scholar]
  • 58. Hildebrand D. P., Lim K. T., Rosell F. I., Twitchett M. B., Wan L., Mauk A. G. (1998) Spectroscopic and functional studies of a novel quadruple myoglobin variant with increased peroxidase activity. J. Inorg. Biochem. 70, 11–16 [DOI] [PubMed] [Google Scholar]
  • 59. Ivancich A., Dorlet P., Goodin D. B., Un S. (2001) Multifrequency high field EPR study of the tryptophanyl and tyrosyl radical intermediates in wild-type and the W191G mutant of cytochrome c peroxidase. J. Am. Chem. Soc. 123, 5050–5058 [DOI] [PubMed] [Google Scholar]
  • 60. Rittle J., Green M. T. (2010) Cytochrome P450 compound I. Capture, characterization, and C–H bond activation kinetics. Science 330, 933–937 [DOI] [PubMed] [Google Scholar]
  • 61. Schünemann V., Lendzian F., Jung C., Contzen J., Barra A. L., Sligar S. G., Trautwein A. X. (2004) Tyrosine radical formation in the reaction of wild type and mutant cytochrome P450cam with peroxy acids. A multifrequency EPR study of intermediates on the millisecond time scale. J. Biol. Chem. 279, 10919–10930 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES